Research Education
What Is MOTS-c? A Research Overview of the Mitochondrial-Derived Peptide
Key points
- MOTS-c is a 16-amino-acid peptide encoded inside the mitochondrial MT-RNR1 gene, not in nuclear DNA.
- The founding work linked it to the folate cycle and AMPK activation in cells (Lee et al., 2015).
- Exercise raised endogenous levels in human sampling; the performance findings came from mice (Reynolds et al., 2021).
- The longevity literature rests on one hypothesis paper and one variant association, not outcome data.
Mitochondria were studied for decades as metabolic machinery and little else. That shifted once researchers showed the mitochondrial genome also encodes peptides that act as signalling molecules.
MOTS-c is the most cited of them after humanin. It now appears across metabolic, exercise and ageing literature, often with more certainty than the underlying papers support.
A peptide encoded outside the nucleus
Mitochondrial-derived peptide. A short peptide translated from a small open reading frame inside mitochondrial DNA rather than the nuclear genome. MOTS-c is one; humanin is the other well-characterised example.
The name expands to mitochondrial open reading frame of the 12S rRNA-c. The coding sequence sits within MT-RNR1, the mitochondrial 12S ribosomal RNA gene, and yields a 16-residue peptide.
That origin is the reason the molecule attracts attention. Mitochondrial DNA is small, maternally inherited and highly conserved, so a functional peptide written into it implies a signalling route from the organelle outward. Lee and colleagues described the peptide in 2015 and characterised it as a mitochondrially encoded regulator acting beyond the mitochondrion.
Metabolic and AMPK research
The original characterisation was metabolic. In cultured cells, the peptide’s actions inhibited the folate cycle and the de novo purine biosynthesis tethered to it, and this was linked to activation of AMP-activated protein kinase (Lee et al., 2015). AMPK is a well-mapped cellular energy sensor, which is why the result travelled quickly.
The same paper included a murine arm. Treated mice were reported as protected against age-dependent and high-fat-diet-induced insulin resistance and against diet-induced obesity, relative to controls. Those endpoints were measured in mice, not in people.
Because AMPK sits at the centre of cellular energy balance, MOTS-c is often discussed alongside other mitochondrial research compounds such as NAD+ and its precursors.
Exercise, muscle and mitochondrial stress
Reynolds and colleagues reported in 2021 that exercise induced endogenous MOTS-c expression in skeletal muscle and in circulation in human sampling. That is a measurement of the body’s own peptide, not an intervention result.
The performance data in the same study came from mice across young, middle-aged and old groups, including a late-life intermittent regimen. In vitro work suggested myoblast adaptation to metabolic stress.
A separate strand concerns retrograde signalling. Kim and colleagues reported in 2018 that the peptide moved from cytoplasm to nucleus in cells under glucose restriction or oxidative challenge, associating with stress-responsive transcription factors. Shen and colleagues later reported Nrf2/ARE and NF-κB readouts in H9c2 cardiomyoblast cultures under oxidative stress (Shen et al., 2022).
Ageing genetics and the longevity claim
Fuku and colleagues noted that the m.1382A>C variant alters the MOTS-c coding sequence and suggested it may be among the putative mechanisms behind high longevity in Japanese populations. The article is a two-page hypothesis piece in Aging Cell. It proposes; it does not demonstrate.
Zempo and colleagues examined the same polymorphism and reported, in a meta-analysis of three Japanese cohorts, that males carrying the C-allele showed a higher prevalence of type 2 diabetes. The same variant therefore carries a metabolic association pointing in the opposite direction from the longevity framing.
Both papers describe a population-specific polymorphism in Northeast Asian cohorts. Neither tested the synthetic peptide as an intervention, and neither reports a longevity outcome.
The research record at a glance
Reading MOTS-c claims accurately means holding the model system next to the finding. The table below pairs each research area with the system it was measured in.
| Research area | Model system | Reported finding |
|---|---|---|
| Metabolic signalling | Cultured cells | Folate-cycle inhibition, AMPK activation (Lee et al., 2015) |
| Insulin sensitivity | Mice | Protection against diet-induced insulin resistance (Lee et al., 2015) |
| Exercise response | Human sampling | Endogenous expression rose in muscle and circulation (Reynolds et al., 2021) |
| Physical capacity | Mice | Differences in performance across age groups (Reynolds et al., 2021) |
| Stress response | Cultured cells | Cytoplasm-to-nucleus movement under metabolic stress (Kim et al., 2018) |
| Population genetics | Japanese cohorts | C-allele associated with higher type 2 diabetes prevalence in males (Zempo et al., 2021) |
How these findings get over-read
Common mistakes
- Reading a hypothesis paper as evidence. The Fuku longevity article proposes a mechanism in two pages, yet is cited as though it reported an association.
- Merging the human and murine arms. Reynolds et al. measured endogenous expression in humans and performance in mice. Summaries collapse the two into a single human claim.
- Treating association as direction. The m.1382A>C variant is linked to type 2 diabetes prevalence in males; that is correlation in a specific population.
- Generalising one cell line. H9c2 cardiomyoblast readouts describe that culture system, not tissue behaviour.
- Trusting circulating values. Assay methods differ, and reported plasma concentrations are inconsistent between groups.
MOTS-c has a well-supported molecular identity, a plausible signalling role, and preclinical data not yet replicated as a human outcome. Aūra Research supplies third-party tested MOTS-c alongside the rest of the best sellers range, with batch purity data published for every lot.
All products sold by Aūra Research are strictly for laboratory research purposes only. They are not intended for human or animal consumption, medical, or therapeutic use.
References
- Lee, C., Zeng, J., Drew, B.G. et al. (2015). The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism. https://pubmed.ncbi.nlm.nih.gov/25738459/
- Kim, K.H., Son, J.M., Benayoun, B.A. et al. (2018). The mitochondrial-encoded peptide MOTS-c translocates to the nucleus to regulate nuclear gene expression in response to metabolic stress. Cell Metabolism. https://pubmed.ncbi.nlm.nih.gov/29983246/
- Reynolds, J.C., Lai, R.W., Woodhead, J.S.T. et al. (2021). MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications. https://pubmed.ncbi.nlm.nih.gov/33473109/
- Fuku, N., Pareja-Galeano, H., Zempo, H. et al. (2015). The mitochondrial-derived peptide MOTS-c: a player in exceptional longevity? Aging Cell. https://pubmed.ncbi.nlm.nih.gov/26289118/
- Zempo, H., Kim, S.J., Fuku, N. et al. (2021). A pro-diabetogenic mtDNA polymorphism in the mitochondrial-derived peptide, MOTS-c. Aging. https://pubmed.ncbi.nlm.nih.gov/33468709/
- Shen, C., Wang, J., Feng, M. et al. (2022). The mitochondrial-derived peptide MOTS-c attenuates oxidative stress injury and the inflammatory response of H9c2 cells through the Nrf2/ARE and NF-κB pathways. Cardiovascular Engineering and Technology. https://pubmed.ncbi.nlm.nih.gov/34859377/